TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 102 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q1 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $402,000 | +6.9% | 130,920 | +119.5% | 0.35% | -26.1% |
| Q4 2017 | $376,000 | +22.1% | 59,646 | +32.5% | 0.47% | +1023.8% |
| Q3 2017 | $308,000 | +5.5% | 45,001 | +10.1% | 0.04% | -4.5% |
| Q2 2017 | $292,000 | +137.4% | 40,885 | +54.4% | 0.04% | -74.0% |
| Q1 2016 | $123,000 | – | 26,478 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 293,675 | $14,061,000 | 4.76% |
| BB BIOTECH AG | 1,507,114 | $71,497,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 893,076 | $42,368,000 | 1.77% |
| Opaleye Management Inc. | 65,000 | $3,084,000 | 1.23% |
| COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT | 390,294 | $18,515,000 | 1.14% |
| Granite Point Capital Management, L.P. | 75,206 | $3,568,000 | 1.04% |
| Granahan Investment Management | 705,601 | $33,474,000 | 0.95% |
| Iguana Healthcare Management, LLC | 50,000 | $2,372,000 | 0.75% |
| Eventide Asset Management | 290,000 | $13,758,000 | 0.74% |
| Rhenman & Partners Asset Management AB | 107,400 | $5,095,000 | 0.61% |